Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab	Relapsing Multiple Sclerosis (RMS)	Active, not recruiting	Phase 3	2026-08-10		NCT06869785

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Novartis Pharmaceuticals	432

63 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Advent Neurology Clinic	Roeland Park	United States	1
AdventHealth	Orlando	United States	29
Alabama Neurology Associates PC	Birmingham	United States	3
Aqualane Clinical Research	Naples	United States	23
Atlanta Neuroscience Institute	Atlanta	United States	6
Axiom Brain Health	Tampa	United States	4
Caribbean Center for Clinical Research Inc	Guaynabo	Puerto Rico	2
Carum Research	Dallas	United States	2
CenExcel Clinical Research	Los Alamitos	United States	1
Cleveland Clinic Foundation	Las Vegas	United States	3
Conquest Research	Vienna	United States	6
Ctr for Neurology and Spine	Phoenix	United States	3
CU Anschutz Med Campus	Aurora	United States	3
Dayton Center for Neurological Disorders	Centerville	United States	5
DelRicht Research	New Orleans	United States	16
Elite Clinical Research	Miami	United States	3
First Choice Neurology	Boca Raton	United States	1
Fullerton Neuro and Headache Ctr	Fullerton	United States	5
Hackensack University Medical Ctr	Hackensack	United States	4
Henry Ford Hospital	Detroit	United States	6
International Neurorehab Institute	Lutherville	United States	2
Josephson Wallack Munshower Neurology PC	Indianapolis	United States	3
Medical College of Wisconsin	Milwaukee	United States	483
MedStar Washington Hospital Center	Washington D.C.	United States	207
Memorial Healthcare System	Hollywood	United States	31

Clinical trials